Hostname: page-component-7c8c6479df-24hb2 Total loading time: 0 Render date: 2024-03-29T06:34:21.877Z Has data issue: false hasContentIssue false

Expression of Neuronal mRNAs in Alzheimer Type Degeneration of the Nervous System

Published online by Cambridge University Press:  18 September 2015

Arthur W. Clark*
Affiliation:
Departments of Pathology and Clinical Neuroscience, University of Calgary, Calgary
Irma M. Parhad
Affiliation:
Departments of Pathology and Clinical Neuroscience, University of Calgary, Calgary
*
Department of Pathology, University of Calgary, 3330 Hospital Drive, N.W., Calgary, Alberta, Canada
Rights & Permissions [Opens in a new window]

Abstract:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

There is extensive evidence for decrements of gene expression in AD, at several levels in the process. There is also evidence for increments of expression of some genes. Message for the amyloid precursor protein (APP), for example, is elevated in surviving neurons of certain subcortical populations in AD. We evaluated expression of message for APP as well as for certain neuronal and glial cytoskeletal proteins in the cortex of six cases of AD. Neuronal mRNAs, including that for APP, were significantly decreased when compared with control cortex, whereas the glial mRNA was increased. We have projected studies to determine the evolution of these mRNA decrements in Alzheimer-type degeneration. The rationale for these studies and preliminary findings are discussed.

Type
Research Article
Copyright
Copyright © Canadian Neurological Sciences Federation 1989

References

REFERENCES

1.Crapper Mclachlan, DR, Lewis, PN. Alzheimer’s disease: Errors in gene expression. Can J Neurol Sci 1985; 12: 15.CrossRefGoogle Scholar
2.Selkoe, DJ. Biochemistry of altered brain proteins in Alzheimer’s disease. Ann Rev Neurosci 1989; 12: 463490.CrossRefGoogle ScholarPubMed
3.Crapper, DR, Quittkat, S, De Boni, U. Altered chromatin conformation in Alzheimer’s disease. Brain 1979; 102: 483495.CrossRefGoogle ScholarPubMed
4.Lewis, PN, Lukiw, WJ, De Boni, U, et al. Changes in chromatin structure associated with Alzheimer’s disease. J Neurochem 1981; 37: 11931202.CrossRefGoogle ScholarPubMed
5.Dayan, AD, Ball, MJ. Histometric observations on the metabolism of tangle-bearing neurons. J Neurol Sci 1973; 19: 433436.CrossRefGoogle Scholar
6.Mann, DMA, Neary, D, Yates, PO, et al. Alterations in protein synthetic capability of nerve cells in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 1981; 44: 97102.CrossRefGoogle ScholarPubMed
7.Uemura, E, Hartmann, HA, Quantitative studies of neuronal RNA on the subiculum of demented old individuals. Brain Res Bull 1979; 4: 301305.CrossRefGoogle ScholarPubMed
8.Guillemette, JG, Wong, L, Crapper Mclachlan, DR, et al. Characterization of messenger RNA from the cerebral cortex of control and Alzheimer-afflicted brain. J Neurochem 1986; 47: 987997.CrossRefGoogle ScholarPubMed
9.Langstrom, NS, Anderson, JP, Lindroos, HG, et al. Alzheimer’s dis-ease-associated reduction of polysomal mRNA translation. Mol Brain Res 1989; 5:259269.CrossRefGoogle ScholarPubMed
10.Sajdel-Sulkowska, EM, Marotta, CA. Functional messenger RNA from the postmortem human brain: Comparison of aged normal with Alzheimer’s disease. In: Sohal, RS, Birnbaum, LS, Cutler, RG, eds. Molecular Biology of Aging: Gene Stability and Gene Expression. New York: Raven Press 1985: 243256.Google Scholar
10.Sajdel-Sulkowska, EM, Marotta, CA. Alzheimer’s disease brain: Alterations in RNA levels and in a ribonuclease inhibitor complex. Science 1984; 225: 947949.Google Scholar
12.Maschoff, K, White , CL III, Jennings, LW, et al. Ribonuclease activities and distribution in Alzheimer’s and control brains. J Neurochem 1989; 52: 10711078.Google Scholar
13.Taylor, GR, Carter, GI, Crow, TJ, et al. Recovery and measurement of specific RNA species from postmortem brain tissue: A general reduction in Alzheimer’s disease detected by molecular hybridization. Exp Mol Pathol 1986; 44: 111116.Google Scholar
14.Morrison, MR, Pardue, S, Maschoff, K, et al. Brain messenger RNA levels and ribonuclease activity in Alzheimer’s disease. Biochem Soc Trans 1987; 15: 133134.Google Scholar
15.Martin, DP, Schmidt, RE, Distefano, PS, et al. Inhibitors of protein synthesis and RNA synthesis prevent neuronal death caused by nerve growth factor deprivation. J Cell Biol 1988; 106: 829844.Google Scholar
16.Appel, SH. A unifying hypothesis for the cause of amyotrophic lat-eral sclerosis, Parkinsonism, and Alzheimer’s disease. Ann Neurol 1981; 10:499505.Google Scholar
17.Mobley, WC, Rutkowski, JL, Tennekoon, G., et al. Choline acetyltransferase activity in striatum of neonatal rats increased by nerve growth factor. Science 1985; 229:284287.Google Scholar
18.Ball, MJ, Nuttall, K. Neurofibrillary tangles, granulovacuolar degen-eration, and neuron loss in Down syndrome: Quantitative comparison with Alzheimer dementia. Ann Neurol 1980; 7: 462465.Google Scholar
19.Mann, DMA, Yates, PO, Marcyniuk, B. Alzheimer’s presenile dementia, senile dementia of Alzheimer type and Down’s syndrome in middle age form an age related continuum of pathological changes. Neuropathol Appi Neurobiol 1984; 10: 185207.Google Scholar
20.Kang, J, Lemaire, HG, Unterbeck, A, et al. The precursor of Alzheimer’s disease amyloid A4 protein resembles a cell-surface receptor. Nature 1987; 325: 733736.Google Scholar
21.Ponte, p, Gonzalez-DeWhitt, , Schilling, J, et al. A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors. Nature 1988; 331: 525527.Google Scholar
22.Tanzi, RE, Mcclatchey, AI, Lampen, ED, et al. Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer’s disease. Nature 1988; 331: 528530.Google Scholar
23.Kitaguchi, N, Takahashi, Y, Tokushima, Y, et al. Novel precursor of Alzheimer’s disease amyloid protein shows protease inhibitory activity. Nature 1988; 331:530532 .Google Scholar
24.Tanzi, RE, Gusella, JF, Watkins, PC, et al. Amyloid (ß) protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science 1987; 235:880884 .Google Scholar
25.Goldgaber, D, Lerman, MI, Mcbrice, OW, et al. Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer’s disease. Science 1987; 235: 877880.Google Scholar
26.Bahmanyar, S, Higgins, GA, Goldgaber, D, et al. Localization of amyloid ? protein messenger RNA in brains from patients with Alzheimer’s disease. Science 1987; 237:7780.Google Scholar
27.Goedert, M. Neuronal localization of amyloid beta protein precursor mRNA in normal human brain and in Alzheimer’s disease. EMBOJ 1987; 6: 36273632.Google Scholar
28.Neve, RL, Finch, EA, Dawes, LR. Expression of the Alzheimer amy- loid precursor gene transcripts in the human brain. Neuron 1988; 1: 669677.Google Scholar
29.Schmechel, DE, Burkhart, Goldgaber D, et al. Cellular localization of messenger RNA encoding amyloid-beta-protein in normal tissue and in Alzheimer disease. Alz Dis Assoc Disor 1988; 2: 96111.Google Scholar
30.Delabar, JM, Goldbar, D,Lamour, Y, et al. ß amyloid gene duplication in Alzheimer’s disease and karyotypically normal Down syndrome. Science 1987; 235: 13901392.Google Scholar
31.St George-Hyslop, PH, Tanzi, RE,Polinsky, RJ, et al. Absence of duplication of chromosome 21 genes in familial and sporadic Alzheimer’s disease. Science 1987; 238: 664666.Google Scholar
32.Tanzi, RE, Bird, ED,Latt, SA, et al. The amyloid ? protein gene is not duplicated in brains from patients with Alzheimer’s disease. Science 1987; 238: 666669.Google Scholar
33.Podlisny, MB, Lee, G,Selkoe, DJ. Gene dosage of the amyloid ß precursor protein in Alzheimer’s disease. Science 1987; 238: 669671.Google Scholar
34.Cohen, ML, Golde, TE,Usiak, MF, et al. In situ hybridization of nucleus basalis neurons shows increased ß-amyloid mRNA in Alzheimer disease. Proc Natl Acad Sci USA 1988; 85:12271231.Google Scholar
35.Palmen, MR, Golde, TE,Cohen, ML, et al. Amyloid protein precur- sor messenger RNAs: Differential expression in Alzheimer’s disease. Science 1988; 241: 10801084.Google Scholar
36.Higgins, GA, Lewis, DA,Bahmanyar, S, et al. Differential regulation of amyloid-ß protein mRNA expression within hippocampal neuronal subpopulations in Alzheimer disease. Proc Natl Acad Sci USA 1988; 85: 12971301.Google Scholar
37.Whitson, JS, Selkoe, DJ,Cotman, CW. Amyloid ß protein enhances the survival of hippocampal neurons in vitro. Science 1989; 243: 14881490.Google Scholar
38.Marotta, CA, Chou, WG,Majocha, RE, et al. Overexpression of amyloid precursor protein A4 (ß-amyloid) immunoreactivity in genetically transformed cells: Implications for a cellular model of Alzheimer amyloidosis. Proc Natl Acad Sci USA. 1989; 86: 337341.Google Scholar
39.Mobley, WC, Neve, RL,Prusiner, SB, et al. Nerve growth factor increases mRNA levels for the prion protein and the ß-amyloid protein precursor in developing hamster brain. Proc Natl Acad Sci USA 1988; 85: 98119815.Google Scholar
40.Clark, AW, Krekoski, CA, Parhad, IM, et al. Altered expression of genes for amyloid and cytoskeletal proteins in Alzheimer cortex. Ann Neurol 1989; 25: 331339.Google Scholar
41.Julien, JP, Grosveld, F, Yazdanbaksh, K, et al. The structure of a human neurofilament gene (NF-L): A unique exon-intron organization in the intermediate filament gene family. Biochimica et Biophysica Acta 1987; 909:1020.Google Scholar
42.Lewis, SA, Lee, MGS, Cowan, NJ. Five mouse tubulin isotypes and their regulated expression during development. J Cell Biol 1985; 101: 852861.Google Scholar
43.Lewis, SA, Balcarek, JM, Krek, V, et al. Sequence of a cDNA clone encoding mouse glial fibrillary acidic protein: Structural conservation of intermediate filaments. Proc Natl Acad Sci USA 1984; 81: 27432746.Google Scholar
44.Hansen, LA, Deteresa, R, Davies, P, et al. Neocortical morphometry, lesion counts, and choline acetyltransferase levels in the age spectrum of Alzheimer’s disease. Neurology 1988; 38: 4854.Google Scholar
45.Crapper Mclachlan, DR, Lukiw, WJ, Wong, L, et al. Selective messenger RNA reduction in Alzheimer’s disease. Mol Brain Res 1988; 3: 255262.Google Scholar
46.Johnson, SA, Pasinetti, GM, May, PC, et al. Selective reduction of mRNA for the ß-amyloid precursor protein that lacks a Kunitz-type protease inhibitor motif in cortex from Alzheimer brains. Exp Neurol 1988; 102: 264268.Google Scholar
47.Tanaka, S, Nakamura, S, Ueda, K, et al. Three types of amyloid protein precursor mRNA in human brain: Their differential expression in Alzheimer’s disease. Biochem Biophys Res Comm 1988; 157: 472479.Google Scholar
48.Tagliavini, F, Giaccone, G, Fragione, B, et al. Cortical pre-amyloid deposition in Alzheimer patients and normals (abstract). J Neuropathol Exp Neurol 1988; 47: 332.Google Scholar
49.Katzman, R, Terry, R, Deteresa, R, et al. Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques. Ann Neurol 1988; 23: 138144.Google Scholar
50.Yamaguchi, H, Hirai, S, Morimatsu, M, et al. Diffuse type of senile plaques in the brains of Alzheimer-type dementia. Acta Neuropathol (Beri) 1988; 77: 113119.Google Scholar
51.Bancher, C, Brunner, C, Lassmann, H, et al.Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer’s disease. Brain Res 1989; 477: 9099.Google Scholar
52.Terry, D, Hansen, LA, Deteresa, R, et al. Senile dementia of the Alzheimer type without neocortical neurofibrillary tangles. J Neuropathol Exp Neurol 1987; 46: 262268.Google Scholar
53.Mann, DMA, Marcyniuk, B, Yates, PO, et al. The progression of the pathological changes of Alzheimer’s disease in frontal and temporal neocortex examined both at biopsy and at autopsy. Neuropathol Appi Neurobiol 1988; 14: 177195.Google Scholar
54.Goodison, K, Clark, AW, Parhad, IM, et al. Neuronal gene expression in Down’s syndrome cortex (abstract). J Neuropathol Exp Neurol 1989; 48: 355.Google Scholar